date:Oct 25, 2018
shorten the time patients feel sick, said Debra Birnkrant, M.D., director of the Division of Antiviral Products in the FDAs Center for Drug Evaluation and Research. Having more treatment options that work in different ways to attack the virus is important because flu viruses can become resistant to antiviral drugs.
The safety and efficacy of Xofluza, an antiviral drug taken as a single oral dose, was demonstrated in two randomized controlled clinical trials of 1,832 patients where participants